Skip to main content

Table 4 Multivariate linear regression for change in EQ-5D VAS score

From: Improvements in quality of life associated with biphasic insulin aspart 30 in type 2 diabetes patients in China: results from the A1chieve® observational study

Variables Coefficient P-value
Intercept 5.4377 0.1041
Macro-complications (yes = 1, no = 0) -0.6064 0.3188
Micro-complications (yes = 1, no = 0) 1.4226 0.0067
Duration of diabetes 0.02993 0.5239
Age 0.02403 0.2699
Male -0.839 0.0944
BMI at baseline -0.1454 0.0554
Pre_study treatment (Insulin naïve = 1, insulin users = 0) -0.5474 0.3547
HbA1c at baseline 0.3459 0.0013
SBP at baseline 0.0208 0.1661
Total cholesterol at baseline 0.4528 0.0817
HDL at baseline -2.3537 <.001
LDL at baseline -0.7543 0.0138
Total hypoglycaemia at baseline (yes = 1, no = 0) 0.01457 0.9628
Major hypoglycaemia at baseline (yes = 1, no = 0) 6.957 <.001